OXYCOIL— 510(k) K854239

Substantially Equivalent

Chad Therapeutics, Inc.

FDA 510(k) clearance K854239 for OXYCOIL, Substantially Equivalent on 1985-11-14. Applicant: Chad Therapeutics, Inc..

Clearance details

Applicant: Chad Therapeutics, Inc.
Product code: Code BYX
Advisory panel: Anesthesiology
Date received: 1985-10-21
Decision date: 1985-11-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chatsworth, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.